Aprogen Pharmaceuticals Inc (003060) — Tangible Net Worth Ratio
Aprogen Pharmaceuticals Inc (003060) has a Tangible Net Worth Ratio of 98.2% as of September 2025. This metric is calculated by deducting intangible assets (₩5.59 Billion) from net assets (₩315.16 Billion) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See 003060 net working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Aprogen Pharmaceuticals Inc Tangible Net Worth Ratio (2009–2024)
This chart shows how Aprogen Pharmaceuticals Inc's Tangible Net Worth Ratio has changed across 17 annual periods from 2009 to 2024. As of September 2025, the ratio stands at 98.2%, reflecting net assets of ₩315.16 Billion with intangible assets of ₩5.59 Billion KRW. See how many days can Aprogen Pharmaceuticals Inc fund operations to measure how many days the company can operate on defensive assets alone.
Annual Tangible Net Worth Ratio for Aprogen Pharmaceuticals Inc (2009–2024)
The table below presents the year-by-year Tangible Net Worth Ratio for Aprogen Pharmaceuticals Inc from 2009 to 2024, covering 17 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see market value of Aprogen Pharmaceuticals Inc.
| Year | Tangible NW Ratio | Net Assets (KRW) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2024 | 98.6% | ₩378.69 Billion | ₩5.12 Billion | ₩590.98 Billion | ▲ +0.3 pp |
| 2023 | 98.3% | ₩368.69 Billion | ₩6.24 Billion | ₩589.40 Billion | ▼ -0.4 pp |
| 2022 | 98.7% | ₩510.41 Billion | ₩6.46 Billion | ₩684.14 Billion | ▼ -0.8 pp |
| 2021 | 99.5% | ₩597.18 Billion | ₩2.80 Billion | ₩614.62 Billion | ▲ +0.1 pp |
| 2020 | 99.4% | ₩598.36 Billion | ₩3.64 Billion | ₩615.31 Billion | ▲ +0.4 pp |
| 2019 | 99.0% | ₩347.64 Billion | ₩3.51 Billion | ₩365.28 Billion | ▲ +1.2 pp |
| 2018 | 97.8% | ₩150.51 Billion | ₩3.29 Billion | ₩217.06 Billion | ▲ +3.6 pp |
| 2017 | 94.2% | ₩77.86 Billion | ₩4.52 Billion | ₩158.27 Billion | ▲ +0.5 pp |
| 2016 | 93.7% | ₩78.12 Billion | ₩4.89 Billion | ₩128.69 Billion | ▼ -3.7 pp |
| 2015 | 97.5% | ₩67.75 Billion | ₩1.70 Billion | ₩85.22 Billion | ▼ -1.3 pp |
| 2014 | 98.8% | ₩62.11 Billion | ₩740.21 Million | ₩84.83 Billion | ▼ -0.2 pp |
| 2013 | 99.0% | ₩56.55 Billion | ₩550.07 Million | ₩78.26 Billion | ▲ +3.8 pp |
| 2012 | 95.2% | ₩68.51 Billion | ₩3.29 Billion | ₩93.08 Billion | ▼ -0.5 pp |
| 2011 | 95.7% | ₩73.49 Billion | ₩3.14 Billion | ₩116.33 Billion | ▲ +2.7 pp |
| 2010 | 93.0% | ₩42.81 Billion | ₩2.98 Billion | ₩78.70 Billion | ▲ +0.5 pp |
| 2010 | 92.5% | ₩41.38 Billion | ₩3.10 Billion | ₩67.64 Billion | ▲ +6.4 pp |
| 2009 | 86.1% | ₩25.18 Billion | ₩3.49 Billion | ₩59.07 Billion | — |